Literature DB >> 31246291

Melanoma.

Conor H O'Neill1, Charles R Scoggins1.   

Abstract

Current recommendations by the United States Preventive Services Task Force do not support screening for skin cancer. Melanoma is unique among cancers because detection is through visual inspection. Development of technologies that aid visual inspection have supported screening strategies in high-risk populations such as older fair skinned males with personal or family history of melanoma. Clearly delineating these populations and appropriate utilization of these newer technologies will be imperative in future screening paradigms.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  melanoma; screening; skin cancer

Mesh：

Year:  2019        PMID： 31246291     DOI： 10.1002/jso.25604

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  15 in total

1.  L-Theanine inhibits melanoma cell growth and migration via regulating expression of the clock gene BMAL1.

Authors:  Ruyi Zhang; Shuangning Zheng; Zhen Guo; Yanan Wang; Guocui Yang; Zhimin Yin; Lan Luo
Journal:  Eur J Nutr       Date:  2021-09-20       Impact factor: 5.614

2.  The molecular mechanisms of vulpinic acid induced programmed cell death in melanoma.

Authors:  Sevcan Yangın; Demet Cansaran-Duman; Gamze Guney Eskiler; Sümer Aras
Journal:  Mol Biol Rep       Date:  2022-08-12       Impact factor: 2.742

3.  Clinical application effect of Pembrolizumab in the treatment of advanced cutaneous malignant melanoma.

Authors:  Lei Fu; Hui Zhang; Jingwen Jiang; Xuewu Chen; Lang Chen; Hui Gong
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

4.  Lycorine hydrochloride inhibits melanoma cell proliferation, migration and invasion via down-regulating p21Cip1/WAF1.

Authors:  Shaomin Shi; Chongyang Li; Yanli Zhang; Chaowei Deng; Mengqin Tan; Guangzhao Pan; Juan Du; Yacong Ji; Qian Li; Hanghua Liang; Wei Liu; Leiyang Guo; Gaichao Zhao; Yaling Liu; Hongjuan Cui
Journal:  Am J Cancer Res       Date:  2021-04-15       Impact factor: 5.942

Review 5.  Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions.

Authors:  Massimo Ralli; Andrea Botticelli; Irene Claudia Visconti; Diletta Angeletti; Marco Fiore; Paolo Marchetti; Alessandro Lambiase; Marco de Vincentiis; Antonio Greco
Journal:  J Immunol Res       Date:  2020-06-28       Impact factor: 4.818

6.  A pooled analysis of the prognostic value of PD-L1 in melanoma: evidence from 1062 patients.

Authors:  Jing Yang; Meilian Dong; Yifang Shui; Yue Zhang; Zhigang Zhang; Yin Mi; Xiaoxiao Zuo; Li Jiang; Ke Liu; Zheyan Liu; Xiaobin Gu; Yonggang Shi
Journal:  Cancer Cell Int       Date:  2020-03-30       Impact factor: 5.722

Review 7.  Nanocarrier-Based Drug Delivery for Melanoma Therapeutics.

Authors:  Mingming Song; Chang Liu; Siyu Chen; Wenxiang Zhang
Journal:  Int J Mol Sci       Date:  2021-02-13       Impact factor: 5.923

Review 8.  Pyroptosis: mechanisms and diseases.

Authors:  Pian Yu; Xu Zhang; Nian Liu; Ling Tang; Cong Peng; Xiang Chen
Journal:  Signal Transduct Target Ther       Date:  2021-03-29

9.  Inhibitory effect of kaempferol on mouse melanoma cell line B16 in vivo and in vitro.

Authors:  Di Qiang; Cao Ci; Wenbei Liu; Jun Wang; Caifeng He; Bihua Ji; Xuefei Shao
Journal:  Postepy Dermatol Alergol       Date:  2020-04-07       Impact factor: 1.837

10.  Low Blue Dose Photodynamic Therapy with Porphyrin-Iron Oxide Nanoparticles Complexes: In Vitro Study on Human Melanoma Cells.

Authors:  Simona Nistorescu; Ana-Maria Udrea; Madalina Andreea Badea; Iulia Lungu; Mihai Boni; Tatiana Tozar; Florian Dumitrache; Valentin-Adrian Maraloiu; Roua Gabriela Popescu; Claudiu Fleaca; Ecaterina Andronescu; Anca Dinischiotu; Angela Staicu; Mihaela Balas
Journal:  Pharmaceutics       Date:  2021-12-10       Impact factor: 6.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.